Clinician Attendance at Post-Mortem Discussions
Hyponatraemia Inquiry · Report of the Inquiry into Hyponatraemia-related Deaths · Issued 31 January 2018 · Addressed to: HSC Trusts
Source — verbatim from the inquiry
●Inquiry recommendation
Where possible, treating clinicians should attend for clinico-pathological discussions at the time of post-mortem examination and thereafter upon request.
Hyponatraemia Inquiry, Report of the Inquiry into Hyponatraemia-related Deaths · 31 Jan 2018 Source PDF →
Response — verbatim from government
●HSC Trusts
Guidance issued on clinician attendance at clinico-pathological discussions.
HSC Trusts · 1 Mar 2018 Written response →
Evidence trail — what's actually happened since
No published activity has been recorded against this recommendation yet.
Each entry above links to a primary source — gov.uk written statement, consultation response document, or inspection report. The Index does not characterise government intent; it tracks what has been published.
How this page is built
Source and Response are verbatim from primary documents. The Evidence trail records published activity since — written statements, consultation outcomes, inspection findings, parliamentary references. The Index does not paraphrase or characterise intent; it tracks what has been published. Where the evidence is the absence of action (a missed deadline, a slipped timetable), that absence is documented from primary sources rather than inferred.
This recommendation's data is verified periodically against primary sources. The Index is monitored for staleness weekly.